Search results for " ACTIVATION"

showing 10 items of 1535 documents

Canakinumab in systemic juvenile idiopathic arthritis: real-world data from a retrospective Italian cohort

2021

Abstract Objective The objective of this study was to use real-world data to evaluate the effectiveness and safety of canakinumab in Italian patients with systemic JIA (sJIA). Methods A retrospective multicentre study of children with sJIA was performed. Clinical features, laboratory parameters and adverse events were collected at baseline, and 6 and 12 months after starting canakinumab. The primary outcome measure of effectiveness was clinically inactive disease (CID) off glucocorticoids (GCs) treatment at 6 months. Results A total of 80 children from 15 Italian centres were analysed. Of the 12 patients who started canakinumab in CID while receiving anakinra, all maintained CID. Of the 68 …

medicine.medical_specialtyMultivariate analysissystemic juvenile idiopathic arthritisArthritisJuvenileAntibodies Monoclonal HumanizedcanakinumabAntibodiessystemic juvenile idiopathic arthritis.Settore MED/38 - Pediatria Generale E SpecialisticaRheumatologyInternal medicineMonoclonalmedicinecanakinumab; clinically inactive disease; systemic juvenile idiopathic arthritis; Antibodies Monoclonal Humanized; Child; Glucocorticoids; Humans; Retrospective Studies; Arthritis Juvenile; Macrophage Activation SyndromeHumanscanakinumab clinically inactive disease systemic juvenile idiopathic arthritis Antibodies Monoclonal Humanized Child Glucocorticoids Humans Retrospective Studies Arthritis Juvenile Macrophage Activation SyndromePharmacology (medical)clinical inactive disease.Adverse effectChildHumanizedGlucocorticoidsRetrospective StudiesUnivariate analysisAnakinrabusiness.industryclinically inactive diseaseArthritisMacrophage Activation Syndromemedicine.diseaseArthritis JuvenileCanakinumabMacrophage activation syndromeCohortSystemic juvenile idiopathic arthritibusinessmedicine.drug
researchProduct

Studies on the mechanism of PMN activation III. by lymphokines.

1983

The influence of a guinea pig lymphokine preparation on the oxidative metabolism of human and guinea pig granulocytes of various sources was investigated. A dose-dependent increase of the oxidative burst following lymphokine challenge was observed. It occurred in unstimulated guinea pig peripheral polymorphonuclear leukocytes (PMN) and in prestimulated PMN obtained from the peritoneal cavity after glycogen injection as well. The lymphokine effect on the oxidative metabolism is not species-restricted because the guinea pig lymphokine preparation elicits an oxidative burst in human PMN, too. The increase caused by lymphokines is nearly of the same order of magnitude as that obtained with zymo…

medicine.medical_specialtyNeutrophilsGuinea PigsBiologyLymphocyte ActivationGuinea pigPeritoneal cavitychemistry.chemical_compoundInternal medicinemedicineMigration inhibitionAnimalsAscitic FluidHumansLymphokinesOxidative metabolismGlycogenZymosanLymphokineZymosanHematologyGeneral MedicineRespiratory burstEndocrinologymedicine.anatomical_structurechemistryCell Migration InhibitionCell DivisionThymidineBlut
researchProduct

Studies on the mechanism of PMN activation II. by triggering the alternative pathway of complement activation

1982

By means of cobra venom factor (CVF) it is demonstrated that the stimulation of hexosemonophosphate shunt (HMPS) of human polymorphonuclear leukocytes (PMN) by zymosan (Z) and dextran sulfate (DS) is caused by at least two modes of activation: (a) via activation caused by phagocytosis, (b) via activated alternative pathway of complement activation (APC). Active factors of APC presented with phagocytizable objects strongly enhance activation of PMN. The effect of APC can be observed in serum-containing as well as in serum-free cultures. It can be demonstrated that in serum-free cultures the factors of APC participating in the activation of PMN are supplied by monocytes. By the use of synthet…

medicine.medical_specialtyNeutrophilsPhagocytosisComplement Pathway AlternativeDose-Response Relationship ImmunologicStimulationMonocyteschemistry.chemical_compoundPhagocytosisInternal medicinemedicineHumansComplement ActivationHematologyChemistryDextran SulfateZymosanZymosanDextransComplement C3HematologyGeneral MedicinePeptide FragmentsCell biologyComplement systemDextran sulfateBiochemistryComplement C3aAlternative complement pathwayCobra venom factorBlut
researchProduct

n-3 Fatty Acids Modulate T-Cell Calcium Signaling in Obese Macrosomic Rats

2004

Objective: We investigated the effects of a diet containing EPAX-7010, rich in PUFAs such as eicosapentaenoic acid [20:5(n-3)] and docosahexaenoic acid [22:6(n-3)], i.e., a PUFA/EPAX regimen, on T-cell activation in diabetic pregnant rats and their obese pups. Research Methods and Procedures: Mild hyperglycemia in pregnant rats was induced by intraperitoneal injection of streptozotocin on Day 5 of gestation. T-cell blastogenesis was assayed by using 3H-thymidine, whereas intracellular free calcium concentrations ([Ca2+]i) were measured by using Fura-2 in diabetic pregnant rats and their obese offspring. Results: Concavalin-A-stimulated T-cell proliferation was decreased in both pregnant dia…

medicine.medical_specialtyOffspringT-LymphocytesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentIntraperitoneal injectionPregnancy in DiabeticsMedicine (miscellaneous)Gestational AgeLymphocyte ActivationDiabetes Mellitus ExperimentalFetal MacrosomiaEndocrinologyDietary Fats UnsaturatedPregnancyDiabetes mellitusInternal medicineFatty Acids Omega-3Concanavalin AmedicineAnimalsObesityRats Wistarchemistry.chemical_classificationCalcium metabolismbusiness.industryIonomycinPublic Health Environmental and Occupational Healthmedicine.diseaseStreptozotocinEicosapentaenoic acidRatsEndocrinologychemistryDocosahexaenoic acidThapsigarginCalciumFemalebusinessSpleenSignal TransductionFood SciencePolyunsaturated fatty acidmedicine.drugObesity Research
researchProduct

Atherosclerosis, inflammation and Chlamydia pneumoniae

2009

Coronary heart disease is the single most common cause of illness and death in the developed world. Coronary atherosclerosis is by far the most frequent cause of ischemic heart disease, and plaque disruption with superimposed thrombosis is the main cause of the acute coronary syndromes of unstable angina, myocardial infarction, and sudden death. Atherosclerosis is the result of a complex interaction between blood elements, disturbed flow, and vessel wall abnormality, involving several pathological processes: inflammation, with increased endothelial permeability, endothelial activation, and monocyte recruitment; growth, with smooth muscle cell proliferation, migration, and matrix synthesis; …

medicine.medical_specialtyPathologyATHEROSCLEROSIS INFECTIONUnstable anginabusiness.industryInflammationChlamydia Coronary atherosclerosis Coronary heart disease PhlogosisReviewmedicine.diseaseSudden deathThrombosisEndothelial activationInternal medicinemedicineCardiologyMyocardial infarctionmedicine.symptomCardiology and Cardiovascular MedicinebusinessCoronary atherosclerosisCalcification
researchProduct

Inflammation, Endothelial Dysfunction and Arterial Stiffness as Therapeutic Targets in Cardiovascular Medicine

2016

In the last decades, many factors thought to be associated with the atherosclerotic process and cardiovascular events have been studied, and some of these have been shown to correlate with clinical outcome, such as arterial stiffness, endothelial dysfunction and immunoinflammatory markers. Arterial stiffness is an important surrogate marker that describes the capability of an artery to expand and contract in response to pressure changes. It can be assessed with different techniques, such as the evaluation of PWV and AIx. It is related to central systolic pressure and it is an independent predictor of cardiovascular morbidity and mortality in hypertensive patients, type 2 diabetes, end-stage…

medicine.medical_specialtyPathologyEndotheliumPopulation030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineDrug DiscoverymedicineAnimalsHumansPlatelet activationEndothelial dysfunctioneducationInflammationPharmacologyeducation.field_of_studySurrogate endpointbusiness.industryCardiovascular AgentsArteriesmedicine.diseasemedicine.anatomical_structureBlood pressureCardiovascular DiseasesCardiovascular agentArterial stiffnessCardiologyEndothelium Vascularbusiness030217 neurology & neurosurgeryCurrent Pharmaceutical Design
researchProduct

Fructose 2,6-bisphosphate and glycolytic flux in skeletal muscle of swimming frog

1990

AbstractGlycolytic flux in skeletal muscle is controlled by 6-phosphofructokinase but how this is achieved is controversial. Brief exercise (swimming) in frogs caused a dramatic increase in the phosphofructokinase activator, fructose 2,6-bisphosphate, in working muscle. The kinetics of phosphofructokinase suggest that in resting muscle, the enzyme is inhibited by ATP plus citrate and that the increase in fructose 2,6-bisphosphate is part of the mechanism to activate phosphofructokinase when exercise begins. When exercise was sustained, fructose 2,6-bisphosphate in muscle was decreased as was the rate of lactate accumulation. Glycolytic flux and the content of fructose 2,6-bisphosphate appea…

medicine.medical_specialtyPhosphofructokinase-1Rana temporariaBiophysicsSkeletal musclePhysical exerciseMotor ActivityBiologyBiochemistrychemistry.chemical_compoundStructural BiologyInternal medicineFructosediphosphatesGeneticsmedicineAnimalsGlycolysisLactic AcidExerciseMolecular BiologySwimmingchemistry.chemical_classificationMusclesSkeletal muscleFructoseCell BiologyEnzyme ActivationKineticsFructose 26-bisphosphateEndocrinologymedicine.anatomical_structureEnzymeBiochemistrychemistryFructose 26-bisphosphateLactates6-PhosphofructokinaseAnuraHexosediphosphatesGlycolysisFlux (metabolism)PhosphofructokinaseFEBS Letters
researchProduct

Greater Strength Gains after Training with Accentuated Eccentric than Traditional Isoinertial Loads in Already Strength-Trained Men

2016

As training experience increases it becomes more challenging to induce further neuromuscular adaptation. Consequently, strength trainers seek alternative training methods in order to further increase strength and muscle mass. One method is to utilize accentuated eccentric loading, which applies a greater external load during the eccentric phase of the lift as compared to the concentric phase. Based upon this practice, the purpose of this study was to determine the effects of 10 weeks of accentuated eccentric loading vs. traditional isoinertial resistance training in strength-trained men. Young (22 ± 3 years, 177 ± 6 cm, 76 ± 10 kg, n = 28) strength-trained men (2.6 ± 2.2 years experience) w…

medicine.medical_specialtyPhysiologyIsometric exerciseConcentriclcsh:PhysiologyMuscle hypertrophy03 medical and health sciences0302 clinical medicinePhysiology (medical)Internal medicineCross-sectional areaMedicineEccentricta315Leg pressOriginal Researcheccentric-overloadlcsh:QP1-981business.industryWork (physics)Resistance trainingResistance Trainingvoluntary activationTwitch interpolationHypertrophy030229 sport sciencesM-wavecross-sectional areaCardiologyPhysical therapyresistance traininghypertrophybusiness030217 neurology & neurosurgeryFrontiers in Physiology
researchProduct

Hypercholesterolemia and haemostatic function changes

1990

Patients with hypercholesterolemia have elevated levels of LDL and reduced plasma concentration of HDL.

medicine.medical_specialtyPlatelet aggregationbusiness.industrynutritional and metabolic diseasesHaemostatic functionFamilial hypercholesterolemiamedicine.diseasePlatelet reactivityEndocrinologyInternal medicinePlasma concentrationMedicinelipids (amino acids peptides and proteins)Platelet activationbusiness
researchProduct

Moderate-Load Muscular Endurance Strength Training Did Not Improve Peak Power or Functional Capacity in Older Men and Women

2017

The present study determined the effects of muscular endurance strength training on maximum strength and power, functional capacity, muscle activation and hypertrophy in older men and women. Eighty-one men and women acted as an intervention group while 22 acted as non-training controls (age range 64–75 y). Intervention training included super-sets (i.e., paired exercises, immediately performing the second exercises following completion of the first) with short rest intervals (30–60 s between sets) at an intensity of 50–60% one-repetition maximum (1-RM) for 15–20 repetitions. Concentric leg press actions measured maximum strength (1-RM) and concentric peak power. Functional capacity was asse…

medicine.medical_specialtyPower walkingPhysiologylepoConcentriclcsh:PhysiologyMuscle hypertrophyresistance03 medical and health scienceswalking0302 clinical medicinePhysical medicine and rehabilitationPhysiology (medical)rest intervalmedicinevoimakkuusLeg pressta315Original Researchtaudinkestävyyslcsh:QP1-981resistanssibusiness.industryagingtimed-up-and-goTwitch interpolationMuscle activation030229 sport sciencesFatigue limitIntensity (physics)kävelyikääntyminenPhysical therapyportaatbusinessintensityhypertrophy030217 neurology & neurosurgerystair climb
researchProduct